selinexor
Showing 26 - 50 of 101
Amyloid, Amyloidosis, AL Amyloidosis Trial in New York (Selinexor, Dexamethasone)
Suspended
- Amyloid
- +2 more
- Selinexor
- Dexamethasone
-
New York, New YorkWeill Cornell Medicine - Multiple Myeloma Center
May 17, 2022
Soft Tissue Sarcoma, Malignant Peripheral Nerve Sheath Tumor (MPNST), Leiomyosarcoma Trial in Toronto (Selinexor)
Recruiting
- Soft Tissue Sarcoma
- +3 more
- Selinexor
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Apr 7, 2022
AML, Adult Trial in Hangzhou, Shanghai, Wuhan (Selinexor, Azacitidine, Venetoclax)
Not yet recruiting
- AML, Adult
- Selinexor
- +2 more
-
Hangzhou, China
- +3 more
Feb 12, 2023
Multiple Myeloma Trial in Guangzhou (Selinexor, Bortezomib, Lenalidomide)
Recruiting
- Multiple Myeloma
- Selinexor
- +3 more
-
Guangzhou, Guangdong, China
- +3 more
Aug 16, 2022
Extramedullary Multiple Myeloma Trial in Wuhan (Selinexor, CT103A)
Recruiting
- Extramedullary Multiple Myeloma
- Selinexor
- CT103A
-
Wuhan, Hu Bei, ChinaTongji Hospital, Tongji Medical College, Huazhong University of
May 17, 2022
Wilms Tumor, Rhabdoid Tumor, Malignant Peripheral Nerve Sheath Tumors Trial in United States (Selinexor)
Recruiting
- Wilms Tumor
- +6 more
- Selinexor
-
Los Angeles, California
- +10 more
Aug 2, 2023
MGMT-Methylated Glioblastoma, Recurrent Glioblastoma, IDH-Wildtype Trial (Selinexor, Temozolomide)
Not yet recruiting
- MGMT-Methylated Glioblastoma
- Recurrent Glioblastoma, IDH-Wildtype
- Selinexor
- Temozolomide
- (no location specified)
Jun 28, 2022
Multiple Myeloma Trial in Shanghai (Selinexor, Thalidomide, Lenalidomide)
Recruiting
- Multiple Myeloma
- Selinexor
- +4 more
-
Shanghai, Shanghai, ChinaShanghai Changzheng Hospital
Mar 3, 2022
Advanced Urothelial Carcinoma, Locally Advanced Urothelial Carcinoma, Metastatic Urothelial Carcinoma Trial in Sacramento
Recruiting
- Advanced Urothelial Carcinoma
- +3 more
- Pembrolizumab
- Selinexor
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Jun 28, 2022
Gliosarcoma, Newly Diagnosed, Glioblastoma Trial run by the National Cancer Institute (NCI) (Selinexor, Temozolomide, Generic
Recruiting
- Gliosarcoma
- +2 more
- Selinexor
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Apr 7, 2022
Advanced Alveolar Soft Part Sarcoma, Advanced Soft Tissue Sarcoma, Metastatic Alveolar Soft Part Sarcoma Trial run by the NCI
Recruiting
- Advanced Alveolar Soft Part Sarcoma
- +3 more
- Atezolizumab
- +5 more
-
Bethesda, Maryland
- +1 more
Jan 28, 2023
Solid Tumor Malignancy Trial in Hackensack (Selinexor, Irinotecan)
Withdrawn
- Solid Tumor Malignancy
- Selinexor
- Irinotecan
-
Hackensack, New JerseyJohn Theurer Cancer Center at HackensackUMC
Dec 14, 2021
DLBCL Germinal Center B-Cell Type Trial in China (Selinexor, Rituximab, Cyclophosphamide)
Recruiting
- DLBCL Germinal Center B-Cell Type
- Selinexor
- +5 more
-
Guangzhou, Guangdong, China
- +5 more
Aug 16, 2022
Multiple Myeloma, Refractory Trial in Greece, Israel (Selinexor, Dexamethasone, Bortezomib)
Recruiting
- Multiple Myeloma, Refractory
- Selinexor
- +2 more
-
Patra, Achaia, Greece
- +15 more
Apr 4, 2022
Soft Tissue Sarcoma Trial in Toronto (Selinexor, Doxorubicin)
Completed
- Soft Tissue Sarcoma
- Selinexor
- Doxorubicin
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Nov 26, 2021
Refractory Multiple Myeloma Trial in United States (selinexor, carfilzomib, dexamethasone)
Recruiting
- Refractory Multiple Myeloma
- selinexor
- +2 more
-
Scottsdale, Arizona
- +4 more
Apr 1, 2022
Locally Advanced Unresectable or Metastatic Melanoma Trial in United States (Selinexor, Pembrolizumab)
Recruiting
- Locally Advanced Unresectable or Metastatic Melanoma
- Selinexor
- Pembrolizumab
-
Los Angeles, California
- +12 more
Jun 30, 2022
Prolymphocytic Leukemia, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Mantle Cell Lymphoma Trial in Columbus, Salt
Active, not recruiting
- Prolymphocytic Leukemia
- +4 more
- Selinexor
- +3 more
-
Columbus, Ohio
- +1 more
Apr 29, 2022
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Rochester (Carfilzomib, Dexamethasone, Pomalidomide)
Recruiting
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Carfilzomib
- +5 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jun 3, 2022
Sarcoma,Soft Tissue Trial in Barcelona, Madrid, Zaragoza (Selinexor)
Recruiting
- Sarcoma,Soft Tissue
- Selinexor
-
Barcelona, Spain
- +5 more
Nov 16, 2021
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Stage IV Pancreatic Cancer Trial in
Suspended
- Acinar Cell Adenocarcinoma of the Pancreas
- +2 more
- gemcitabine hydrochloride
- +4 more
-
Detroit, Michigan
- +1 more
Feb 2, 2022
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in United States (drug, biological, other)
Recruiting
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Carfilzomib
- +4 more
-
Des Moines, Iowa
- +8 more
Jan 12, 2023
Relapsed or Refractory DLBCL Trial in United States (Selinexor, Rituximab, Bendamustine)
Suspended
- Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- Selinexor
- +9 more
-
Tucson, Arizona
- +17 more
Jan 24, 2023
B-cell Lymphoma Trial in Belgium, France (selinexor, Rituximab, Dexamethasone)
Completed
- B-cell Lymphoma
- selinexor
- +6 more
-
Bruxelles, Belgium
- +7 more
Dec 6, 2021